Jeff Reeves

Jeff Reeves

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for InvestorPlace.com since the beginning of 2010.  

Jeff’s work has appeared in numerous finance publications and broadcast outlets, including The Wall Street Journal network, CNBC, TheStreet.com, Fox Business Channel, USA Today and a host of others.

View some of his TV appearances on YouTube, or check out his writing links below.

Jeff has also penned an eBook, The Frugal Investor’s Guide to Finding Great Stocks: 11 Free Resources to Help Beginners Identify Fantastic Investments.

Write Jeff at editor@investorplace.com, or follow him on Twitter @JeffReevesIP.

Recent Articles

Bono: The Dumbest Smartphone Investor Ever

By Jeff Reeves

As a musician, U2's Bono is rock royalty. He was inducted to the Rock and Roll hall of Fame with bandmates in 2005, the group is the most-decorated act in Grammy history with 22 total awards, and U2's total record sales top more than 145 million copies worldwide. But as an investor, Bono could rank as one of the worst Wall Street wannabes of all time.

7 Stocks to Buy Before China’s Travel Boom (CEA, ZNH, CTFO, CTRP, HMIN, PCLN, UTA)

By Jeff Reeves

A top exec at the United Nations World Tourism Organization recently said China will surpass France as the largest tourist destination by 2015, if not sooner. That means big profits for top China travel stocks China Eastern Airlines (CEA), China Southern Airlines (ZNH), China TransInfo Technology (CTFO), Ctrip.com (CTRP), Home Inns and Hotels (HMIN), Priceline.com (PCLN) and Universal Travel Group (UTA).

Pharmacy Stocks Helped by Healthcare Reform (CVS, ESRX, RAD, MHS, WAG, WMT)

By Jeff Reeves

President Obama signed the health care reform bill into law Tuesday, and despite the huffing and puffing of Republicans, there's not much that can be done to change things. The legislation gives 32 million currently uninsured Americans access to medical procedures and prescription drugs -- making them prospective customers of leading prescription providers like CVS Caremark (CVS), Express Scripts (ESRX), Rite Aid (RAD), Medco Health Solutions (MHS), Walgreens (WAG) and Wal-Mart (WMT).

Starbucks SBUX to Pay First-Ever Dividend

By Jeff Reeves

Starbucks (SBUX) just announced today that it will begin paying regular quarterly dividends of 10 cents a share -- a move Wall Street greeted by bidding up shares about 2% after the announcement. If the move was meant to perk up investor sentiment, it certainly worked. The Seattle company also said it will buy back an extra 15 million SBUX shares over a previously announced 6.3 million buyback plan.

3 Stocks That May Snatch Up Gamestop

By Jeff Reeves

Gamestop (GME) is Wall Street's favorite dog to kick around. Shares are down -20% from the March lows of 2009 despite a red-hot rally of about 70% in the broader market. But that may not be fair, and competitors like Best Buy (BBY), Blockbuster (BBI) and Walmart (WMT) may want to buy out GME soon.

Load More